Interesting facts
Interesting Facts about Ethyl N-[10-(3-Morpholinopropanoyl)phenothiazin-2-yl]carbamate
Ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate is a fascinating compound that has garnered interest in the field of medicinal chemistry. Here are some intriguing details about this compound:
- Pharmaceutical Relevance: It belongs to the class of phenothiazine derivatives, which are known for their diverse pharmacological properties, especially in antipsychotic and antiemetic treatments.
- Molecular Complexity: The presence of the morpholine group adds to the molecular complexity of this compound, potentially influencing its interactions at the receptor level.
- Action Mechanism: Compounds in this class often exhibit their effects by blocking dopamine receptors in the brain, which is essential for their therapeutic effects.
- Hybrid Structure: The combination of phenothiazine and morpholine moieties in its structure signifies a strategic design aiming to enhance efficacy while minimizing side effects.
- Versatile Applications: Beyond psychiatric treatments, there is research exploring the potential uses of this compound in tackling other conditions, such as certain types of cancer and infections.
As a scientist or chemistry student, it's exciting to delve into the nuances of such compounds. As the great chemist Linus Pauling once said, "The best way to have a good idea is to have a lot of ideas." With compounds like ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate, one can certainly explore numerous avenues in drug discovery and development!
Synonyms
MORICIZINE
Moracizine
31883-05-3
Moracizina
Moracizinum
Ethyl 10-(3-morpholinopropionyl)phenothiazine-2-carbamate
2GT1D0TMX1
EN-313 FREE BASE
CHEBI:6997
ethyl N-{10-[3-(morpholin-4-yl)propanoyl]-10H-phenothiazin-2-yl}carbamate
Carbamic acid, (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)-, ethyl ester
DTXSID4023335
Moracizin
ethyl 10-(beta-N-morpholinylpropionyl)phenothiazine-2-carbamate
CARBAMIC ACID, [10-[3-(4-MORPHOLINYL)-1-OXOPROPYL]-10H-PHENOTHIAZIN-2-YL]-, ETHYL ESTER
[10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl]-carbamic acid ethyl ester
ethyl N-(10-(3-(morpholin-4-yl)propanoyl)-10H-phenothiazin-2-yl)carbamate
(10-(3-Morpholin-4-yl-propionyl)-10H-phenothiazin-2-yl)-carbamic acid ethyl ester
N-(10-(3-(morpholin-4-yl)propanoyl)-10H-phenothiazin-2-yl)ethoxycarboximidic acid
N-{10-[3-(morpholin-4-yl)propanoyl]-10H-phenothiazin-2-yl}ethoxycarboximidic acid
RefChem:819399
DTXCID803335
C01BG01
EN313
250-854-5
Moricizine [USAN]
Moracizinum [INN-Latin]
Moracizina [INN-Spanish]
EN-313
C22H25N3O4S
ethyl N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carbamate
Moracizine (INN)
Moracizine [INN]
Moricizine (USAN)
EN 313
ethyl {10-[3-(morpholin-4-yl)propanoyl]-10H-phenothiazin-2-yl}carbamate
Ethyl (10-(3-morpholinopropanoyl)-10H-phenothiazin-2-yl)carbamate
G 214
NCGC00016809-01
NCGC00016809-07
EINECS 250-854-5
UNII-2GT1D0TMX1
Phenothiazine-2-carbamic acid, 10-(3-morpholinopropionyl)-, ethyl ester
Ethyl (10-(3-(4-morpholinyl)-1-oxopropyl)-10H-phenothiazin-2-yl)carbamate
MFCD00336543
MORICIZINE [MI]
Prestwick0_001051
Prestwick1_001051
Prestwick2_001051
Prestwick3_001051
MORICIZINE [VANDF]
MORACIZINE [MART.]
TimTec1_000772
CHEMBL1075
MORACIZINE [WHO-DD]
Oprea1_682904
Oprea1_701257
SCHEMBL16794
BSPBio_001002
CBDivE_008814
MLS001201823
BIDD:GT0499
SPBio_002931
BPBio1_001104
GTPL7244
orb1706953
SCHEMBL29599149
HMS1536D02
HMS2852B19
BCP14374
ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate
HY-B0615
STK370502
AKOS001487682
ethyl [10-(3-morpholin-4-ylpropanoyl)-10H-phenothiazin-2-yl]carbamate
DB00680
Carbamic acid,[10-[3-(4-morpholinyl)-1-oxopropyl]-10H-phenothiazin-2-yl]-,ethyl ester
NCGC00016809-02
NCGC00016809-03
NCGC00016809-04
NCGC00074074-03
SMR000059585
ST012322
CAS-31883-05-3
DB-048124
AB00514710
NS00029189
C07743
D05077
AB00514710-13
883M053
EN300-18530976
Q904071
BRD-K21548250-003-03-5
BRD-K21548250-003-19-1
Ethyl 10-(beta-Morpholinopropionyl)phenothiazine-2-carbamate
[10-[3-(4-morpholinyl)-1-oxopropyl]-10h-phenothiazin-2-yl]-, ethyl ester
ethoxy-N-[10-(3-morpholin-4-ylpropanoyl)phenothiazin-2-yl]carboxamide
Solubility of Ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate
The solubility of ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate is influenced by various factors, most notably its chemical structure and functional groups. This compound contains both hydrophobic and hydrophilic characteristics, leading to intricate solubility behavior:
As a general observation, compounds like ethyl N-[10-(3-morpholinopropanoyl)phenothiazin-2-yl]carbamate often exhibit:
Understanding the solubility of this compound is essential, particularly for pharmaceutical applications, where the availability of the drug can significantly impact its effectiveness in therapeutic settings. Proper solubility assessment is a critical step in formulation development and can dictate the success of the compound's application.